Tumour Biology (TB)

Tumour Biology is a peer-reviewed international journal that publishes high-quality research in the field of oncology and cancer biology. It focuses on experimental, translational, and clinical studies related to tumor development, progression, diagnosis, and treatment. The journal provides a platform for research on tumor markers, molecular biomarkers, cancer signaling pathways, tumor immunology, and personalized cancer therapy. The journal was originally established in 1984 and has since become an important source of scientific knowledge in cancer research. It publishes original research articles, reviews, and clinical studies that explore the biological mechanisms underlying cancer and tumor growth. Special attention is given to emerging areas such as liquid biopsy, cancer genomics, tumor microenvironment, and targeted therapies. Over the years, Tumour Biology has contributed significantly to advances in cancer diagnostics and therapeutic strategies by integrating molecular biology with clinical oncology. It supports interdisciplinary research that bridges laboratory findings with real-world medical applications. The journal is widely indexed in major scientific databases and serves researchers, clinicians, and biomedical scientists working in cancer-related fields.

Tumour Biology (TB) is :-

• International, Peer-Reviewed, Open Access, Refereed, Oncology, Cancer Biology, Tumor Markers, Molecular Oncology, Experimental & Clinical Cancer Research, Biomarker Research, molecular biomarkers, cancer signaling pathways, tumor immunology, personalized cancer therapy, progression, diagnosis, treatment , Online , Bi-Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN E-ISSN: 0289-5447, Established: 1984,
• Provides Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE